TERUMO CORP (TRUMF) Financials
TRUMF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 12.0 billion | 3.4 billion |
| 2023-09-30 | 11.7 billion | 3.3 billion |
| 2023-06-30 | 11.6 billion | 3.2 billion |
| 2023-03-31 | 12.1 billion | 3.7 billion |
TRUMF Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 153.2 million | ? |
| 2023-09-30 | 156.7 million | ? |
| 2023-06-30 | -53.2 million | ? |
| 2023-03-31 | 174.3 million | ? |
TRUMF Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 278.8 million |
| 2023-09-30 | 245.2 million |
| 2023-06-30 | 206.2 million |
| 2023-03-31 | 181.0 million |
TRUMF Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 1.3 billion | - | - |
| 2023-09-30 | 1.4 billion | - | - |
| 2023-06-30 | 1.2 billion | - | - |
| 2023-03-31 | 1.4 billion | - | - |
TRUMF Shares Outstanding
TRUMF Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 113.5 million | 122.7 million | 624.4 million | - |
| 2023-09-30 | 125.4 million | 109.8 million | 554.0 million | - |
| 2023-06-30 | 132.2 million | 106.5 million | 556.9 million | - |
| 2023-03-31 | 147.0 million | 120.5 million | 570.1 million | - |
TRUMF Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 1.7 billion | 797.7 million |
| 2023-09-30 | 1.5 billion | 737.5 million |
| 2023-06-30 | 1.5 billion | 729.6 million |
| 2023-03-31 | 1.5 billion | 776.9 million |
TRUMF
Price: $17.16
Dividend Yield: 1.32%
Forward Dividend Yield: 3.77%
Payout Ratio: 147.00%
Dividend Per Share: 0.65 USD
Earnings Per Share: 0.43 USD
P/E Ratio: 39.79
Exchange: PNK
Sector: Healthcare
Industry: Medical Instruments & Supplies
Market Capitalization: 24.9 billion
Average Dividend Frequency: 2
Years Paying Dividends: 21
DGR3: 3.79%
DGR5: 30.00%
DGR10: 30.00%